Joshua D Lee Selected Research

Buprenorphine (Subutex)

3/2024	Impact of jail-based methadone or buprenorphine treatment on non-fatal opioid overdose after incarceration.
12/2023	Jail-based medication for opioid use disorder and patterns of reincarceration and acute care use after release: A sequence analysis.
9/2023	Integrating Text Messaging in a Low Threshold Telebuprenorphine Program for New York City Residents with Opioid Use Disorder during COVID-19: A Pilot Randomized Controlled Trial.
9/2023	Patient Perceptions of Integrating Meditation-based Interventions in Office-based Opioid Treatment with Buprenorphine: A Mixed-methods Survey.
1/2023	Association between jail-based methadone or buprenorphine treatment for opioid use disorder and overdose mortality after release from New York City jails 2011-17.
12/2022	Polysubstance use before and during treatment with medication for opioid use disorder: Prevalence and association with treatment outcomes.
7/2022	Injecting Opioid Use Disorder Treatment in Jails and Prisons: The Potential of Extended-release Buprenorphine in the Carceral Setting.
1/2022	A Mixed-Methods Evaluation of the Feasibility of a Medical Management-Based Text Messaging Intervention Combined With Buprenorphine in Primary Care.
1/2022	Perceptions and experiences toward extended-release buprenorphine among persons leaving jail with opioid use disorders before and during COVID-19: an in-depth qualitative study.
1/2021	Association between methadone or buprenorphine use during medically supervised opioid withdrawal and extended-release injectable naltrexone induction failure.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joshua D Lee Research Topics

Disease

47	Opioid-Related Disorders (Opiate Addiction) 03/2024 - 02/2009
8	Substance-Related Disorders (Drug Abuse) 05/2022 - 07/2011
5	Multiple Sclerosis 01/2022 - 01/2014
5	Alcoholism (Alcohol Abuse) 06/2021 - 07/2010
4	COVID-19 09/2023 - 12/2020
2	Opiate Overdose 03/2024 - 01/2021
2	Substance Withdrawal Syndrome (Withdrawal Symptoms) 09/2023 - 02/2009
2	Pain (Aches) 09/2023 - 01/2021
1	Chronic Disease (Chronic Diseases) 01/2022
1	Atrial Fibrillation 01/2021
1	Esophageal Neoplasms (Esophageal Cancer) 01/2021
1	Wounds and Injuries (Trauma) 01/2021
1	Critical Illness (Critically Ill) 01/2021
1	Respiratory Insufficiency (Respiratory Failure) 06/2020
1	Infections 01/2020
1	Hepatitis C 01/2020
1	Acquired Immunodeficiency Syndrome (AIDS) 10/2019
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2015
1	Seizures (Absence Seizure) 09/2012
1	Coma (Comas) 09/2012
1	Schizophrenia (Dementia Praecox) 12/2011

Drug/Important Bio-Agent (IBA)

26	Opioid Analgesics (Opioids)IBA 09/2023 - 07/2011
25	Buprenorphine (Subutex)FDA LinkGeneric 03/2024 - 02/2009
20	Naltrexone (ReVia)FDA LinkGeneric 12/2022 - 07/2010
9	Naloxone Drug Combination Buprenorphine FDA Link 01/2022 - 01/2012
6	Methadone (Dolophine)FDA LinkGeneric 03/2024 - 02/2009
3	mu Opioid Receptors (mu Opioid Receptor)IBA 11/2020 - 03/2016
3	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 10/2016 - 01/2016
2	trans-crotonin (CTN)IBA 12/2021 - 11/2016
2	Cocaine (Cocaine HCl)IBA 01/2015 - 07/2011
1	Cytidine Triphosphate (CTP)IBA 12/2022
1	chlorotriphenylsilane (CTPS)IBA 12/2022
1	Methamphetamine (Desoxyn)FDA LinkGeneric 01/2022
1	Natalizumab (Tysabri)FDA Link 01/2022
1	Amphetamine (Amfetamine)FDA LinkGeneric 01/2022
1	Naloxone (Narcan)FDA LinkGeneric 11/2020
1	preproenkephalinIBA 11/2020
1	kappa Opioid Receptors (kappa Opioid Receptor)IBA 11/2020
1	DNA (Deoxyribonucleic Acid)IBA 11/2020
1	TabletsIBA 01/2019
1	insulin receptor-related receptor (IRR)IBA 01/2018
1	Illicit Drugs (Recreational Drugs)IBA 01/2017
1	BenzodiazepinesIBA 01/2015
1	Heroin (Diamorphine)IBA 01/2014
1	25-Hydroxyvitamin D3 1-alpha-Hydroxylase (25 Hydroxyvitamin D3 1 alpha Hydroxylase)IBA 01/2014
1	CannabinoidsIBA 09/2012
1	DysbindinIBA 12/2011

Therapy/Procedure

5	Injections 01/2021 - 07/2010
4	Drug Therapy (Chemotherapy) 12/2021 - 11/2018
2	Continuity of Patient Care 01/2020 - 10/2019
2	Secondary Prevention 01/2016 - 03/2015
1	Retention in Care 03/2024
1	Palliative Care (Palliative Therapy) 01/2021
1	Investigational Therapies (Experimental Therapy) 12/2020
1	Self Administration (Administration, Self) 11/2020
1	Artificial Respiration (Mechanical Ventilation) 06/2020
1	Therapeutics 01/2018
1	Opiate Substitution Treatment 03/2016